概要
技术资料
Document Type | 产品名称 | Catalog # | Lot # | 语言 |
---|---|---|---|---|
Product Information Sheet | Human Recombinant Fractalkine (CX3CL1) | 78051, 78051.1, 78051.2 | All | English |
Safety Data Sheet | Human Recombinant Fractalkine (CX3CL1) | 78051, 78051.1 | All | English |
数据及文献
Data

(A) The biological activity of Human Recombinant Fractalkine (CX3CL1) was tested by its ability to mobilize Ca2+ in CHO-K1/Gα15/hCX3CR1 (human Gα15 and human CX3CR1 stably expressed in CHO-K1 cells) cells. Ca2+ mobilization was measured using a fluorometric assay method. The EC50 is defined as the effective concentration of the growth factor at which Ca2+ mobilization is at 50% of maximum. The EC50 in the example above is less than 1.5 μg/mL. (B) 2 μg of Human Recombinant Fractalkine (CX3CL1) was resolved with SDS-PAGE under reducing (+) and non-reducing (-) conditions and visualized by Coomassie Blue staining. Human Recombinant Fractalkine (CX3CL1) has a predicted molecular mass of 50 - 75 kDa.